These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour. Brooks SA, Leathem AJ. Lancet; 1991 Jul 13; 338(8759):71-4. PubMed ID: 1712062 [Abstract] [Full Text] [Related]
5. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer. Stanton PD, Cooke TG, Oakes SJ, Winstanley J, Holt S, George WD, Murray GD. Br J Cancer; 1992 Nov 13; 66(5):925-9. PubMed ID: 1419638 [Abstract] [Full Text] [Related]
7. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy. Vesalainen S, Nordling S, Lipponen P, Talja M, Syrjänen K. Br J Cancer; 1994 Aug 13; 70(2):309-14. PubMed ID: 8054280 [Abstract] [Full Text] [Related]
8. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer. Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J. Breast Cancer Res Treat; 2005 May 13; 91(1):61-71. PubMed ID: 15868432 [Abstract] [Full Text] [Related]
9. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]. Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J. Cancer Radiother; 2005 Dec 13; 9(8):575-86. PubMed ID: 16243560 [Abstract] [Full Text] [Related]
10. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04. Fisher B, Gunduz N, Costantino J, Fisher ER, Redmond C, Mamounas EP, Siderits R. Cancer; 1991 Oct 01; 68(7):1465-75. PubMed ID: 1893345 [Abstract] [Full Text] [Related]
11. Relationship between DNA ploidy and survival in patients with primary breast cancer. Eskelinen MJ, Pajarinen P, Collan Y, Pesonen E, Alhava E, Kettunen K, Nordling S. Br J Surg; 1989 Aug 01; 76(8):830-4. PubMed ID: 2765840 [Abstract] [Full Text] [Related]
13. The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up. Toikkanen S, Joensuu H, Klemi P. Br J Cancer; 1989 Nov 01; 60(5):693-700. PubMed ID: 2553094 [Abstract] [Full Text] [Related]
15. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S. Oncology; 1996 Nov 01; 53(3):182-91. PubMed ID: 8643219 [Abstract] [Full Text] [Related]
18. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients. Gazic B, Pizem J, Bracko M, Cufer T, Borstnar S, Pohar-Marinsek Z, Us-Krasovec M. Cytopathology; 2008 Oct 01; 19(5):294-302. PubMed ID: 18070112 [Abstract] [Full Text] [Related]
19. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer. Meyer JS, Province MA. Cancer; 1994 Oct 15; 74(8):2287-99. PubMed ID: 7922981 [Abstract] [Full Text] [Related]
20. Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma. Haghbin M, McCue PA, Mansfield CM, Komarnicky LT, Benammar A, Schwartz GF. Am J Clin Oncol; 1996 Feb 15; 19(1):54-8. PubMed ID: 8554037 [Abstract] [Full Text] [Related] Page: [Next] [New Search]